Skip to main content
Aker BioMarine logo

Aker BioMarine — Investor Relations & Filings

Ticker · AKBM ISIN · NO0010886625 LEI · 549300V34T6VWDSYWE64 OL Agriculture, forestry and fishing
Open in API
Filings indexed 508 across all filing types
Latest filing 2023-06-29 Regulatory Filings
Country NO Norway
Listing OL AKBM

About Aker BioMarine

https://www.akerbiomarine.com/

Aker BioMarine is a biotechnology innovator that sustainably harvests Antarctic krill to develop and supply krill-derived ingredients. The company's core business focuses on producing ingredients for the human health and nutrition markets, including nutraceuticals and dietary supplements. It also serves the aquaculture and animal feed sectors with specialized products. Aker BioMarine leverages its vertically integrated supply chain and scientific research to create a portfolio of products that extends to agricultural biostimulants and pharmaceutical applications. The company is committed to sustainable operations and the scientific validation of its marine-based ingredients.

Recent filings

Filing Released Lang Actions
Intention to change Group financial reporting and legal entity structure
Regulatory Filings Classification · 99% confidence The document announces the company's intention to change its Group financial reporting and legal entity structure, detailing the planned reorganization of reporting segments (Feed Ingredients, Human Health Ingredients, Consumer Health Products, Emerging Businesses). It explicitly states that the current structure will be kept through 2023, with the new structure expected in Q1 2024, and promises more information at the Q2 presentation. This is a fundamental change to how the company organizes and reports its business operations and financials, which falls under Capital/Financing Update (CAP) as it directly impacts capital structure presentation, or potentially Regulatory Filings (RNS) if it's a mandatory disclosure. Given the nature of restructuring financial reporting segments and legal entities, 'CAP' (Capital/Financing Update) is a strong fit as it relates to structural changes affecting financial presentation, although 'RNS' is a possibility. However, since it details a structural change affecting financial reporting segments, 'CAP' is more specific than the general 'RNS' fallback. The document is short and is an announcement of an internal structural change, not a full report.
2023-06-29 English
Mandatory notification of trade
Director's Dealing Classification · 100% confidence The document text is titled 'KRT - 1500 Skjema for melding om transaksjoner utført av personer med ledelsesansvar (« primærinnsidere ») og deres nærstående' (Form for notification of transactions executed by persons discharging managerial responsibilities ('insiders') and their connected persons). It details a transaction (Kjøp/Buy) of shares (Aksje) by an individual identified as CEO (MATTS EIRIK JOHANSEN) of the issuer (aker biomarine). This structure and content directly correspond to mandatory reporting of insider trading or director's dealings, which is covered by the 'Director's Dealing' definition. Comparing with definitions: - 10-K/IR: Not a full annual or interim report. - ER/MDA: Not an earnings release or management discussion. - DIV/CAP/SHA: Not primarily about dividends, financing, or general share issues. - DIRS (Director's Dealing): This perfectly matches the content: reporting personal share transactions by company directors and executives. Therefore, the classification is DIRS.
2023-05-31 Norwegian
Mandatory notification of trade
Director's Dealing Classification · 100% confidence The document explicitly states it is a 'Mandatory notification of trade' concerning the CEO, Matts Johansen, purchasing shares. This directly relates to personal share transactions by a company director/executive (insider trading notification). This aligns perfectly with the definition of Director's Dealing (DIRS). The short length (673 chars) and the mention of an 'attached primary insider notification form' might suggest RPA, but the core content is the insider trade itself, making DIRS the most specific and accurate classification.
2023-05-31 English
Aker BioMarine ASA – Registration of share capital increase
Share Issue/Capital Change Classification · 99% confidence The document explicitly announces the 'Registration of share capital increase' related to an Employee Share Purchase Program. It details the resulting new registered share capital and the number of shares. This directly relates to changes in the company's capital structure through the issuance of new shares. This aligns perfectly with the definition for 'Share Issue/Capital Change' (SHA). It is not a general regulatory filing (RNS) because it is highly specific to a capital event, nor is it a transaction in own shares (POS) as it stems from an employee program resulting in new issuance.
2023-05-26 English
Aker BioMarine ASA – Mandatory notification of subscription of shares by primary insiders in Employee Share Purchase Program
Director's Dealing Classification · 100% confidence The document text consists of structured tables detailing transactions involving financial instruments (Aksje/Share) by primary insiders (Primærinnsider) and related parties at Aker BioMarine ASA. Key fields include 'Transaksjonstype' (Tegning/Subscription), 'Pris per enhet' (Price per unit), 'Volum' (Volume), and 'Dato for transaksjonen' (Transaction Date). This format is characteristic of mandatory regulatory filings disclosing insider trading or significant shareholding changes. Specifically, the disclosure of personal share transactions by company directors and executives points directly to the 'Director's Dealing' category. In the context of European regulations (like MAR), these disclosures are often standardized reports of insider transactions. Therefore, the most appropriate classification is Director's Dealing (DIRS).
2023-05-09 Norwegian
Aker BioMarine ASA – Mandatory notification of subscription of shares by primary insiders in Employee Share Purchase Program
Share Issue/Capital Change Classification · 99% confidence The document is a mandatory notification detailing the subscription of new shares by primary insiders (CEO, EVPs, Board Director) under an Employee Share Purchase Program. This involves executives acquiring company stock, which falls under the category of insider transactions or director's dealings. The filing explicitly lists the individuals, the number of shares subscribed, and the resulting total holdings. This directly matches the definition for Director's Dealing (DIRS). Although it involves share subscription, the focus is on the insider's transaction, not a general capital change announcement (SHA) or a general share repurchase (POS).
2023-05-09 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.